🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Epithelial Ovarii › Minnesota › Minneapolis

Qorannoo klinikaalii Kansarii Epithelial Ovarii Minneapolis, MN keessatti

Qorannoo 5 Kansarii Epithelial Ovarii f Minneapolis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Masonic Cancer Center, University of Minnesota, Minneapolis
Umuriin 18 fi ol · Dubartoota · Haaromfame 05-Onk-2026 · NCT06915025

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Namoota walitti qabaa jiraSadarkaa 2
  • University of Minnesota - Minneapolis /ID# 275718, Minneapolis
  • Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 274780, Saint Louis Park · Miili 5 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 29-Ful-2026 · NCT06890338

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Minneapolis
Umuriin 18 fi ol · Dubartoota · Haaromfame 21-Ado-2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Namoota walitti qabaa jiraSadarkaa 3
  • Minnesota Oncology Hematology PA, Minneapolis
Umuriin 18 fi ol · Dubartoota · Haaromfame 02-Ado-2026 · NCT06819007

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Namoota walitti qabaa jiraSadarkaa 2
  • SCRI - Minnesota Oncology Hematology, P.A., Minneapolis
  • University of Minnesota, Minneapolis
Umuriin 18 fi ol · Dubartoota · Haaromfame 23-Mud-2025 · NCT06690775

Qorannoo Kansarii Epithelial Ovarii magaalota biroo keessatti

Qorannoo biroo Minneapolis keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.